| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.099 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.28 | 0.1 |